Antibodies’ proprietary antibody discovery technology and delivers unprecedented success rates in the discovery of functional antibodies to GPCRs. It is built on a deep understanding of immunology and antibody induction enabling us to discover functional antibodies to complex protein targets which have hitherto been intractable to drug discovery.